Arvind Sathyamurthy

Clinical Fellow in Gynaecologic Oncology,Royal Marsden Hospital London, Associate Professor of Radiation Oncology,CMC Vellore

[Praveen Kumar Marimuthu @drmpk91]

Excited to share that our phase 2 trial #NeoLOCUS is now out in @LancetRH_SEAsia! A collective effort from the Head & Neck team @OffCMCVellore led by @todrashish
We report R0 rates, ORR, safety, survival outcomes, tumor immune microenvironment change🧵👇
https://t.co/vjAbbvhZI7

[The Royal College of Radiologists @RCRadiologists]

We had a fantastic time celebrating our New Fellows during yesterday's Admission Ceremony!

Congratulations once again on this momentous occasion 👏

#RCRFellows

[CMC Vellore @OffCMCVellore]

PRAGRAD, a new patient-driven treatment approach for very advanced oral cavity #cancers (which cannot be surgically removed) shows significant improvement in patient outcomes: prospective study by CMC #research team.
Instead of a one-size-fits-all plan, #patients are given the choice of #palliative care or aggressive chemoradiation, promoting shared decision-making and #PatientAutonomy.
It was found that when decision making was shared, more patients were willing to try aggressive chemoradiation; half the number who responded to initial #chemotherapy and continued aggressive treatment, survived over 30 months - 5 times longer than those choosing palliation (6 months). Nearly half survived beyond 2 years - a remarkable outcome for this advanced stage.

Read more: https://t.co/hpafom8Q9S

@ASTRO_org
#RedJournal #CancerCare #PatientChoice

[Arvind Sathyamurthy @Arvind_RadOnc]

@SuyogCancer 🙋🏽

[Vin Paleri @VinPaleri]

Quite the week for head&neck unit @royalmarsdenNHS 3 major outputs. https://t.co/XAt1b2pP6v in @NEJM with Kevin Harrington https://t.co/AlMrph4Uj5 ION in @TheLancet Kate Newbold @DrChrisNutting and @IReC_RM consensus https://t.co/t2SOdlRkvB in @JNCI_Now
ThankYou collaborators

[Arvind Sathyamurthy @Arvind_RadOnc]

@drmpk91 @CancerCareMASCC Congratulations 👏🏽

[Pablo Jiménez @PaulJiL]

💥 First practice-changing trial in over 2 decades for patients with resectable, LA HNSCC #AACR25
🌟EFS ITT 51 PembroSoC vs 30m SoC
🎯HR 0.73 (0.58-0.92)
⏱️OS inmature

Congrats to all my colleagues at @royalmarsdenNHS H&N unit, rest of sites, sponsor💪@OncoAlert @brunolarvol

[Nicholas van As @nickva1]

We're hiring! Clinical Oncology Research Fellow opportunity at @royalmarsdenNHS @ICR_London to work on the landmark PACE trial & future prostate radiotherapy studies. Work with me, @EmmaHall71 @y_suhughes Join us! #OncologyJobs https://t.co/bB9xAA3kfN
@alison_tree @cpeedell

[Ashish Singh @todrashish]

congratulations 🎊
Very important findings, as we try to bring these expensive lifesaving treatment to people who can not afford to pay for the same.. @brunolarvol @FordePatrick @JCO_ASCO @OncoAlert @DrSanjayPopat

[Arvind Sathyamurthy @Arvind_RadOnc]

@Naagashree @syajaman Hi where in London is this?

[Ajoy Oommen John @ajoyojohn]

🧬🚨 New Study Alert! 🚨🧬 Our recent work dived into into BRCA1/2 mutations in India. There is limited data on population specific BRCA mutations in 🇮🇳. We used NGS to analyze 921 Indian women with suspected hereditary breast and ovarian cancer (HBOC). @OffCMCVellore
#BRCA

[CMC Vellore @OffCMCVellore]

39th Annual #Conference of the Association of #RadiationOncologists of India (AROI), #TamilNadu
& #Puducherry Chapter, organised by Dept of #Radiation #Oncology, Ida B Scudder #Cancer Centre, on 20th and 21st. Conference also marked 85th anniversary of the dept at #CMCVellore.

[Nicholas van As @nickva1]

#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients ⁦@DrTolan⁩ @alison_tree⁩ ⁦@cpeedell⁩ @DrAndrewLoblaw⁩ ⁦@EmmaHall71⁩ @ProfJOSullivan⁩ https://t.co/HlFxb3jegQ

[Tejaswi Kanala MD @TSKanala]

Radiation Oncology 101 this #NEETPG season for the uninitiated med student. Most MBBS grads in India come across #RadOnc for the very first time when preparing for NEETPG & a 4 hour lecture doesn't cut what we do in our sacred basements. Here is a primer to help you choose. 1/n

[Bobby Koneru, MD @KoneruMd]

🚨New Book on Low-Dose Radiation for Painful Musculoskeletal Conditions🚨 Free Download Now Available

Over the past year, there has been a remarkable surge of interest in using low-dose radiotherapy to treat painful musculoskeletal conditions like osteoarthritis, plantar fasciitis, tendonitis, and bursitis. Many have inquired about how to initiate a program, secure institutional backing, leverage social media for promotion, and explore the supporting literature for these treatments.

This interest inspired Dr. Richard Shaffer and me to author a book designed to assist radiation oncologists and administrators in launching such programs. The book will serve as an excellent supplement to a structured training program.

❇️ The book is now available. Click on the link below to download 👇

❇️ All I request is for you to hit the repost button below so this can reach as many radiation oncologists as possible 👇

#radonc

https://t.co/94CmCh6BDL

[Josh Thomas Georgy @jtgeorgy]

1/ 📢 Excited to share our study led by @heberrewbright @todrashish & Sujith J Chandy(@ICARS_global) published in @JCOGO_ASCO investigating the role of capsaicin in⬇️CINV: an investigator-initiated RCT @ajoel_84 @ajoyojohn @divyathumaty @OffCMCVellore https://t.co/SgVm4ZYNLT

[Hannah T Balukrishna @HBalukrishna]

Can MRI and CT Radiomics Predict Treatment Outcome in Rectal Cancer? Pre-treatment MRI with clinical features shows potential. Personalization strategies (e.g. aggressive Tx for high-risk, organ preservation for low-risk patients need accurate predictors. https://t.co/mOYtzFFaf6

[Ben O'Leary @nearlobey]

In addition to being a TV and media star, it turns out @VinPaleri is really rather good at #hnscc surgery.

[Henning Willers, MD, FASTRO @HenningWillers]

Kevin Harrington showing exciting clinical and preclinical data on modulating immune response at #ESTRO24‼️

Super impressive clinical responses to ATR inhibition + low dose #radiotherapy in HNSCC🔥 (cant post)

@lauremarignol

[CMC Vellore @OffCMCVellore]

Dept of #Neonatology recently organised an 'NICU Graduates' Reunion' for premature babies who were under their care. More than 40 children with a birth weight of less than a kilo - currently between 2 and 5 years of age - participated along with their families.